FDA Drug Application (103786) for RETAVASE by EKR THERAP

Back to FDA Applications sponsored by EKR THERAP

Application Number103786
Product Number001
FormVIAL
Dosage18.8MG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRETAVASE
Active IngredientRETEPLASE



Back to FDA Applications sponsored by EKR THERAP